References
- Daroff R. B. Diagnosis and therapy. Clinical Neuro-Ophthalmology, J. L. Smith. The CV Mosby Company, St Louis 1980; 62–71
- Fischer K. C., Sch Wartzm An R. J. Oral corticosteroids in the treatment of ocular myasthenia gravis. Neurology 1974; 24: 795–798
- Flier J. Diseases caused by antibodies to receptors. Clin. Immunol. Rev. 1981–1982; I: 215–256
- Miller N. R. Myasthenia gravis: systemic and ocular considerations. Ophthalmology 1979; 86: 2165–2174
- Newsom-Davis J., Vincent A., Wilson Award S. G.D. C. Long term effects of repeated plasma exchange in myasthenia gravis. Lancet 1979; 8114: 464–468
- Olanow C. W., Roses A. D., Fay J. W. The effect of plasmapheresis on post-thymectomy ocular dysfunction. Canad. J. neurol. Sci. 1981; 8: 169–172
- Pinching A. J., Peters D. K., Davis J. N. Remissions of myasthenia gravis following plasma exchange. Lancet December, 1976; 1373–1376